List of works - Jeffrey Pu

Alternative Polyadenylation: a new frontier in post transcriptional regulation

scientific article published on 25 November 2020

Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK inhibition as an Effective Strategy

scientific article published on 20 March 2020

Cloning and structural characterization of ECTACC, a new member of the transforming acidic coiled coil (TACC) gene family: cDNA sequence and expression analysis in human microvascular endothelial cells.

scientific article

Complement blockade with a C1 esterase inhibitor in paroxysmal nocturnal hemoglobinuria

scientific article

Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study

scientific article published on 24 September 2020

Gallbladder carcinosarcoma.

scientific article

Mantle cell lymphoma and its management: where are we now?

scientific article published on 30 January 2019

Natural history of paroxysmal nocturnal hemoglobinuria clones in patients presenting as aplastic anemia

scientific article

Occurrence of acute myeloid leukemia in hydroxyurea-treated sickle cell disease patient

scientific article published on 18 August 2019

Onset of expression of the components of the Kell blood group complex

scientific article published in June 2005

Outcomes of CLL patients treated with sequential kinase inhibitor therapy: a real world experience.

scientific article published on 6 September 2016

PD-1 pathway and its clinical application: A 20year journey after discovery of the complete human PD-1 gene

scientific article published on 23 September 2017

PIGN gene expression aberration is associated with genomic instability and leukemic progression in acute myeloid leukemia with myelodysplastic features

scientific article

Paraneoplastic cerebellar degeneration as an early sign of classical Hodgkin lymphoma

scientific article published on 06 November 2015

Paroxysmal nocturnal hemoglobinuria from bench to bedside

scientific article

Primary myelofibrosis and its targeted therapy.

scientific article

Spontaneously arising red cells with a McLeod-like phenotype in normal donors

scientific article published on 02 April 2009

Successful discontinuation of eculizumab therapy in a patient with aHUS

scientific article published on 18 December 2013

The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy

scientific article published on 24 August 2020

The human PD-1 gene: complete cDNA, genomic organization, and developmentally regulated expression in B cell progenitors

scientific article

The mouse Kell blood group gene (Kel): cDNA sequence, genomic organization, expression, and enzymatic function

scientific journal article

The small population of PIG-A mutant cells in myelodysplastic syndromes do not arise from multipotent hematopoietic stem cells

scientific article

List of works by Jeffrey Pu

Alternative Polyadenylation: a new frontier in post transcriptional regulation

Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK inhibition as an Effective Strategy

Cloning and structural characterization of ECTACC, a new member of the transforming acidic coiled coil (TACC) gene family: cDNA sequence and expression analysis in human microvascular endothelial cells.

Complement blockade with a C1 esterase inhibitor in paroxysmal nocturnal hemoglobinuria

Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study

Gallbladder carcinosarcoma.

Mantle cell lymphoma and its management: where are we now?

Natural history of paroxysmal nocturnal hemoglobinuria clones in patients presenting as aplastic anemia

Occurrence of acute myeloid leukemia in hydroxyurea-treated sickle cell disease patient

Onset of expression of the components of the Kell blood group complex

Outcomes of CLL patients treated with sequential kinase inhibitor therapy: a real world experience.

PD-1 pathway and its clinical application: A 20year journey after discovery of the complete human PD-1 gene

PIGN gene expression aberration is associated with genomic instability and leukemic progression in acute myeloid leukemia with myelodysplastic features

Paraneoplastic cerebellar degeneration as an early sign of classical Hodgkin lymphoma

Paroxysmal nocturnal hemoglobinuria from bench to bedside

Primary myelofibrosis and its targeted therapy.

Spontaneously arising red cells with a McLeod-like phenotype in normal donors

Successful discontinuation of eculizumab therapy in a patient with aHUS

The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy

The human PD-1 gene: complete cDNA, genomic organization, and developmentally regulated expression in B cell progenitors

The mouse Kell blood group gene (Kel): cDNA sequence, genomic organization, expression, and enzymatic function

The small population of PIG-A mutant cells in myelodysplastic syndromes do not arise from multipotent hematopoietic stem cells